Vik Bajaj, managing director at venture capitalist firm Foresite Capital and CEO of Foresite Labs, which focuses on transforming healthcare through data-driven solutions, sat down with MobiHealthNews ...
Symeres has entered a collaboration with Ambagon Therapeutics on molecular glue research in colorectal cancer, aiming to ...
Novel Concepts Medical is proud to announce breakthrough results from its labs in Israel showing that its plant-based formula resulted in over 99% decrease in cell viability of breast cancer cells and ...
Spread the loveA recent study has sparked significant concern within the scientific community regarding the use of Vitamin B3 supplements, particularly those that boost NAD+ (Nicotinamide Adenine ...
Impact of multimodal, multidisciplinary care on clinical outcomes in patients with breast cancer and leptomeningeal carcinomatosis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I ...
Symeres and Ambagon Therapeutics collaborate on molecular glue research in colorectal cancerNijmegen, Netherlands [31.03.2026] – Symeres, a leading CRDMO for drug discovery and development has ...
University of Michigan researchers developed serum albumin-based nanoparticles that delivered plasmid DNA and mRNA into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results